CREB1 and breast carcinoma: Our previous study explored small molecule nAS‐E targeting CREB‐CBP interaction as a cell‐permeable inhibitor to inhibit CREB‐mediated gene transcription.47 In this study, its effects in breast cancer bone metastasis were further investigated.